Mkts

Senti Biosciences Holdings, Inc.

NASDAQ: SNTI
$0.17-0.05 (-23.92%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
0.150.20
52-week range
0.162.88
Today
Open0.17
Previous close0.17
Volume366.3K
Valuation
Market cap5.14M
P/E ratio—
EPS (TTM)-1.76
Income & risk
Dividend / yield—
Beta2.29
Avg volume2.60M
Discussion

SNTI News

Stories mentioning SNTI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue16.000.000.000.000.00
Cost of Goods Sold
Gross Profit0.000.00
Operating Expenses
Research & Development5,2817,76010,51610,0299,2817,7718,6559,151
Sales General & Admin
Total Operating Expenses4,63218,65816,94816,79816,39716,16715,21513,356
Operating Income (Loss)(4,616)(18,636)(16,948)(16,798)(16,397)(16,167)(15,215)(13,356)
Interest Income
Interest Expense
Other Expense200.00190.00223.00209.00178.00205.00(11.00)6.00
Pretax Income
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(4,221)(14,467)(18,126)(14,733)(14,112)(610.00)(28,866)(11,203)
Earnings Per Share (Basic)(0.14)(0.64)(0.69)(0.56)(1.41)(0.13)(6.31)(2.45)
Earnings Per Share (Diluted)(0.14)(0.64)(0.69)(0.56)(1.41)(0.13)(6.31)(2.45)
Weighted Average Shares Outstanding (Basic)30,97222,48326,22826,08110,0134,5964,5774,572
Weighted Average Shares Outstanding (Diluted)30,97222,48326,22826,08110,0134,5964,5774,572

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About SNTI

Senti Biosciences Holdings, Inc. (NASDAQ: SNTI) is a stock listed on the Nasdaq Stock Market under the ticker symbol SNTI. It last traded at $0.1700 (Oct 30, 2026, 4:00 PM ET), down 23.9% on the day. That gives Senti Biosciences a market capitalisation of $5.1M.

Over the past 52 weeks SNTI has traded between $0.1600 and $2.88.

Revenue for the quarter ended Mar 31, 2026 was $16.0K; a net loss of $4.2M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$16.0K-$4.2M-26381.3%
Dec 31, 2025—-$14.5M—
Sep 30, 2025—-$18.1M—
Jun 30, 2025—-$14.7M—

From Senti Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…